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SHORT COMMUNICATION
Bipolar disorders in ICD-11: current status 
and strengths
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Abstract 
Background: The Clinical descriptions and diagnostic guidelines for the ICD-11 Classification of mental and behav-
ioural disorders should soon be finalized. To measure their potential impact, the new proposed definitions of bipolar 
disorders in ICD-11 were applied to data from the Zurich cohort study and compared with the definitions of ICD-10 
and DSM-5.
Results: We found little difference between ICD-11 and ICD-10 in the identification of subjects with bipolar disorders, 
but compared to DSM-5 a considerable increase in the diagnosis of hypomanic episodes and therefore of bipolar-II 
disorders.
Conclusions: Compared to ICD-10 and DSM-5 the definition of hypomanic episodes according to ICD-11 represents 
important progress. A higher prevalence of BP-II disorder makes sense from a clinical point of view. Further transcul-
tural research is needed into whether out-patient treatment should be included as a criterion for hypomania. Pure 
mania is unfortunately missing as an independent and codable disorder in the international diagnostic manuals, 
whether ICD-11 or DSM-5.
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Introduction
The World Health Organization is central to the continu-
ous development of the diagnostic classification of medi-
cal disorders. With the ICD-11 officially approved, the 
next stage in our field will be the publication of the Clini-
cal Descriptions and Diagnostic Guidelines (CDDG) for 
the manual’s Mental and Behavioural Disorders section. 
The guidelines are currently out for consultation and 
comment. From 2022 the ICD-11 should be in worldwide 
use. The ICD review process has taken over ten years, 
partly overlapping with the fifth revision of the DSM of 
the American Psychiatric Association, which was com-
pleted in 2013. From the outset the general aim was to 
harmonise their structure and descriptions in order to 
avoid arbitrary differences (Reed et al. 2019).
Differences persist nonetheless. In its conception the 
ICD-11 is guided by the principles of clinical usefulness 
and global applicability. In particular, its descriptions of 
the “essential features” of mood episodes are not pre-
sented as equivalents of strict diagnostic criteria. Symp-
tom counts or duration cut-offs are generally avoided, 
which is designed to reflect clinical practice and the exer-
cise of clinical judgment. A full account of the changes in 
ICD-11 and their rationale is to be found in (Reed et al. 
2019).
The purpose of this short paper is to compare the defi-
nitions of manic and hypomanic episodes in ICD-11 (as 
it currently stands) (a) briefly with the previous version 
ICD-10 (World Health Organization 1992) and (b) with 
DSM-5 of the American Psychiatric Association (Ameri-
can Psychiatric Association 2013). By applying the crite-
ria to data from the Zurich study, described in detail in 
an earlier publication (Angst et  al. 2016), we can provi-
sionally illustrate some consequences of the revisions.
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Zurich study sample and definitions
The Zurich study is an epidemiological study, which fol-
lowed the probands over a period of 30  years from the 
ages of 19/20 to 49/50. The interview sample was selected 
from an initial cohort of 4547 people (f = 2346; m = 2201) 
representative of the canton of Zurich in Switzerland, 
who were screened in 1978 by the Symptom Checklist 90 
(SCL-90-R) (Derogatis 1977) when they were 19 years old 
(males) or 20 years old (females).
To increase the probability of the development of psy-
chiatric syndromes, a stratified sub-sample of 591 sub-
jects was selected for the longitudinal study. Two-thirds 
of the sample consisted of high scorers (defined as scor-
ing above the 85th percentile of the global severity index 
of the SCL-90-R) (n = 396) and one-third of a random 
sample of those with scores below the 85th percentile 
(n = 195). The use of stratified samples is not uncommon 
in epidemiological research (Dunn et  al. 1999). Alto-
gether, seven interview waves were conducted: in 1979, 
1981, 1986, 1988, 1993, 1999 and 2008. For the present 
analysis only data collected from 1986 onwards were 
used; in 1986 an interview section on mania was added to 
the interview. The initial allocation to the two strata did 
not change over the study’s time span.
The analysis is presented both with the raw figures 
(n = 475 in the period 1986–2008) and with figures after 
reweighting to offset the stratification (n = 2051). For the 
reweighting, the analysis was conducted with the SAS 
procedure PROC SURVEYFREQ.
For the definitions of ICD-11 we have used the docu-
ments available on the internet. For the ICD-10, diag-
nostic criteria for research were subsequently published, 
distinct from of the CDDG for clinicians, (ICD-10 DCR) 
(World Health Organization 1993). These imposed both 
symptom numbers and duration cut-offs, narrowing the 
differences between the ICD and DSM-IV. We applied 
ICD-10 DCR definitions in our analyses of ICD-10 but 
this approach was not extended to ICD-11, as there is no 
indication that diagnostic research criteria will be pro-
duced for this latest revision.
Bipolar disorders in ICD‑11
The mood disorders section in ICD-11 has been reor-
ganized, opening with the description of mood episodes 
(depressive, manic, mixed and hypomanic), which are 
not coded. Codes are ascribed to disorders, which are 
diagnosed on the basis of the pattern of a patient’s mood 
episodes over time. Moreover, in the bipolar and related 
disorders grouping newer research led to the subdivi-
sion of bipolar disorder into types I and II, based on the 
distinction between mania and hypomania (Reed et  al. 
2019). This is in line with DSM-5.
Mania as a diagnosis
Historically bipolar disorders (BP) included mania, 
BP-I, BP-II, hypomania and cyclothymic disorders. The 
international diagnostic manuals do not reflect the full 
affective spectrum. In none of them does mania have 
the status of a separate disorder. Since ICD-10 a manic 
episode has been codable only within mood disorders. 
Those with mania/a manic episode are diagnosed as 
having bipolar-I disorder. ICD-11 continues this tradi-
tion, which is in line with the successive versions of the 
DSM, including DSM-5. This must nonetheless be con-
sidered a loss in both clinical and research terms. There 
is growing evidence from epidemiological, clinical and 
genetic studies that unipolar mania exists as a distinct 
disorder (Merikangas et al. 2014; Baek et al. 2014; Angst 
and Grobler 2015). A recent analysis of data merged 
from seven epidemiological studies of adults found BP-I 
(mania with major depressive disorder) in 323 subjects 
and pure mania in 109, a relatively rare but separate diag-
nosis (Angst et al. 2018).
Major change in the definitions of manic and hypomanic 
syndromes and episodes in ICD‑11 and DSM‑5
The definitions of manic and hypomanic syndromes and 
episodes in the two manuals are now almost identical as 
regards entry criteria, duration, hospitalization, and the 
presence or absence of psychotic features and impair-
ment in social and occupational functioning, albeit with 
the dissimilarities referred to above (essential features vs. 
lettered entry criteria, etc.).
All manic and hypomanic episodes in ICD-11 require 
as defining features:
1. euphoria, irritability or expansiveness, and, increased 
activity or subjective experience of increased energy
2. plus “several “(ICD-11), three or more (DSM 5) of the 
following 7 symptoms:
1. increased talkativeness or pressured speech,
2. flight of ideas,
3. increased self-esteem or grandiosity,
4. decreased need of sleep,
5. distractibility,
6. impulsive reckless behaviour,
7. increase in sexual drive, sociability or goal-
directed activity.
Thus, a diagnosis of bipolar mood disorders in both 
ICD-11 and DSM-5 now requires as an essential entry 
feature not only the presence of elated/euphoric, expan-
sive or irritable mood but in addition, in all cases, 
increased activity/energy; this is in contrast to both 
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ICD-10 and DSM-IV TR (American Psychiatric Associa-
tion 2000) which required as criterion A only the pres-
ence of mood changes. This development is not without 
problems. Earlier, we illustrated the consequences of this 
important conceptual change, as introduced by DSM-
5, with data from the Bridge Study. 810 of 3618 (22.5%) 
patients with Major Depression manifested only one 
mood criterion for bipolarity (elated or irritable). Follow-
ing DSM-IV criteria those patients were diagnosed with 
bipolar disorders, whereas according to DSM-5 they lost 
their bipolarity and were re-diagnosed as having major 
depressive disorder (Angst et al. 2014).
Manic and hypomanic episodes in ICD‑11 compared 
to DSM‑5
DSM-5 defines manic episodes and hypomanic episodes 
slightly more restrictively (as had the ICD-10 DCR) in 
that for cases with mood irritability only (without eupho-
ria) it requires 4 rather than 3 of the 7 symptoms for a 
diagnosis; ICD-11 does not single out irritability in this 
way.
Similarly the minimum duration of a hypomanic epi-
sode is 4+ days in DSM-5 and “several days” in ICD-11 
For the purposes of our analysis several was interpreted 
as 4+ consecutive days.
One further restriction in the definition of a hypomanic 
episode in DSM-5 relates to changes in functioning. In 
DSM-5 criterion C: an unequivocal change in function-
ing uncharacteristic of the person, and criterion D: the 
disturbance in mood and the change in functioning are 
observable by others must be met. In ICD-11 this is less 
categorically expressed as the significant change in the 
usual range of moods and behaviour would be apparent 
to people who know the individual well.
Exclusions
Like DSM-5, ICD-11 excludes syndromes caused by the 
effects of a substance or medication, another medical 
condition (tumour etc.), but now allows the diagnosis of a 
manic or hypomanic episode if the full syndrome persists 
after antidepressant treatment (e.g. medication, ECT, 
light therapy) is discontinued and its direct effects have 
ceased or receded.
Causal attributions and exclusions are, however, known 
to be problematic and not data based.
Comparison of diagnostic systems using data 
from the Zurich study: ICD‑10, ICD‑11 and DSM‑5
ICD‑11 and ICD‑10: manic symptoms, hypomania 
and mania
Comparing ICD-11 with ICD-10 (ICD-10 DCR) our 
analysis (Table 1) found a minimal reduction in the fre-
quency of ICD-11 manic episodes (N = 29) compared to 
ICD-10 (31). On the other hand ICD-11 diagnosed 48 
subjects with a hypomanic episode vs. 40 by ICD-10.
Prevalence rates have to be weighted, because in the 
Zurich study risk cases (high scorers on the SCL-90 R) 
were purposely over-represented (Table 2).
ICD‑11 and DSM‑5: manic symptoms, hypomania 
and mania
ICD-11 and DSM-5 are in close agreement in the diagno-
sis of manic episodes (Table 3) but hypomanic episodes 
are far more frequently identified by ICD-11 (N = 48) 
than DSM-5 (N = 15); only 10 subjects are classified by 
both.
Application of ICD-11 results in prevalence of mania 
in 5.4%, DSM-5 in 4.7%. But hypomania is diagnosed by 
ICD-11 far more frequently in 9.9% compared to DSM-5 
in 2.2%. The prevalence rates are shown in Table 4.
Validity of the ICD‑11 diagnoses
As validators we can provide family history (parents, 
siblings) and lifetime treatment for manic or depressive 
symptoms.
As is clear in Table 5, a positive family history (FH+) is 
strongly correlated with the diagnostic groups of mania 
and hypomania. Both diagnostic subgroups correlate sig-
nificantly in their FH + for mania, suicide/attempts, alco-
hol abuse/dependence and anxiety/panic. But there is no 
association with a FH + for depression or smoking.
Table 6 lists percentage treatment rates for manic and 
depressive symptoms for ICD-11, ICD-10 and DSM-
5. The three diagnostic classifications show very similar 









28 1 2 0 31
Hypomania 0 40 0 0 40
Manic 
symptoms
1 7 144 0 152
Others 0 0 0 252 252
Total 29 48 146 252 475
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validity regarding the treatment of manic symptoms but 
none for the treatment of depressive symptoms.
If ICD currently classifies patients who have been hos-
pitalized for manic syndromes as having manic episodes, 
individuals with manic symptoms who have been treated 
could reasonably be diagnosed as hypomanic. In Table 6 
we show this to be the case for 4 of 149 subjects (2.7%), 
who, if added to the subjects with hypomania, would 
increase their number from 48 to 52. The prevalence rate 
would correspondingly increase from 9.9 to 10.1%. Of 
course further research into this approach is needed.
In order to test the hypothesis of a continuum from 
normal to pathological, one might also look at recur-
rent brief hypomania among those with manic symp-
toms (Angst 1997). It is present in 37 subjects, with a 
prevalence of 7.8%. Cumulatively 23.38% of individu-
als manifested manic, hypomanic or brief hypomanic 
episodes.
Conclusions
Compared to ICD-10 and DSM-5, the current ICD-11 
definition of hypomanic episodes represents important 
progress. Hypomanic episodes will be diagnosed twice 
as frequently as manic episodes. From a clinical point 
Table 2 ICD‑11 vs. ICD‑10: prevalence rates, weighted (%) with 95% confidence intervals
ICD‑11 Mania Hypomania Manic symptoms Others Total
ICD-10 Mania 5.4 (2.4–8.4) 0.05 (0.0–0.1) 0.6 (0.0–1.7) 0 6.0 (2.8–9.2)
Hypomania 0 8.5 (4.7–12.3) 0 0 8.5 (4.7–12.3)
Manic symptoms 0.05 (0.0–0.1) 1.3 (0.0–2.9) 27.1 (21.2–33.1) 0 28.5 (22.5–34.6)
Others 0 0 0 57.0 (50.3–63.7) 57.0 (50.3–63.7)
Total 5.4 (2.4 –8.5) 9.9 (5.8–13.9) 27.7 (21.7–33.7) 57.0 (21.7–33.7) 100









23 0 2 0 25
Hypomania 1 10 4 0 15
Manic 
symptoms
5 37 140 0 182
Others 0 1 0 252 253
Total 29 48 146 252 475
Table 4 ICD‑11 vs. DSM‑5: prevalence rates, weighted (%) with 95% confidence intervals
ICD‑11 mania Hypomania Manic symptoms Others Total
DSM-5 mania 4.1 (1.5–6.8) 0 0.6 (0.0–1.7) 0 4.7 (1.9–7.6)
Hypomania 0.05 (0.0–0.1) 1.5 (3.0–15.1) 0.7 (0.0–1.8) 0 2.2 (0.3–4.1)
Manic symptoms 1.2 (0.0–2.8) 8.3 (4.6–12.1) 26.4 (20.5–32.3) 0 36.0 (29.5–42.7)
Others 0 0.05 (0.0–0.1) 0 57.0 (50.3–63.7) 57.0 (50.4–63.7)
Total 5.4 (2.4–8.5) 9.9 (5.8–13.9) 27.7 (21.7–33.7) 57.0 (50.3–63.7) 100
Table 5 ICD‑11 mania: family history (parents and siblings)
Probands’ responses only; consent to interview relatives was not given
ICD‑11 Mania (29) % Hypomania (48) % Manic symptoms 
(146) %
Others (252) % Chi square
P
Family history
Mania 24.1 18.7 8.9 3.2 < .0001
Depression 62.1 58.3 57.5 49.6 < .284
Suicidality 37.9 12.5 18.5 16.3 < .025
Anxiety/panic 58.6 47.9 32.2 24.6 < .0001
Alcohol abuse 17.2 12.5 24.7 11.5 < .0061
Smoking 72.4 72.3 79.3 71.1 < .389
Page 5 of 5Angst et al. Int J Bipolar Disord             (2020) 8:3 
of view it makes sense that the milder condition should 
occur more often than the severe one. This also means 
that bipolar-II disorder will become a more common 
diagnosis. It should be remembered that hypomanic 
episodes in terms of their social and subjective conse-
quences are not always undesirable. They can be associ-
ated with an increased work capacity and heightened 
creativity. Transcultural research is needed into whether 
out-patient treatment should be included as a criterion 
for a diagnosis of hypomania, in parallel with the hospi-
talization criterion for a manic episode. Finally, ICD-11 
allows greater scope for the exercise of clinical judgment, 
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Table 6 Lifetime treatment for  manic or  depressive 
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a 4 of 149 subjects were treated as out-patients




 ICD.11 26.7 12.5 2.7a .0001
 ICD-10 25.8 15.0 2.6 .0001
 DSM-5 32.0 13.3 4.4 .0001
% Treatment depr. symptoms
 ICD.11 70.0 56.2 53.7 .259
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 DSM-5 64.0 60.0 54.9 .663
